Fayez Sarofim & Co’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$559M Buy
1,212,411
+39,885
+3% +$20.2M 1.43% 22
2025
Q4
$664M Buy
1,172,526
+3,176
+0.3% +$1.69M 1.59% 20
2025
Q3
$528M Buy
1,169,350
+60,210
+5% +$28.9M 1.23% 26
2025
Q2
$609M Sell
1,109,140
-6,869
-0.6% -$3.59M 1.46% 22
2025
Q1
$559M Sell
1,116,009
-15,561
-1% -$8.61M 1.39% 25
2024
Q4
$597M Buy
1,131,570
+47,858
+4% +$24.9M 1.45% 22
2024
Q3
$532M Buy
1,083,712
+36,279
+3% +$16.9M 1.35% 23
2024
Q2
$466M Buy
1,047,433
+161,783
+18% +$64.4M 1.26% 24
2024
Q1
$353M Buy
885,650
+54,700
+7% +$20.7M 1.05% 29
2023
Q4
$323M Buy
830,950
+16,562
+2% +$4.94M 0.99% 30
2023
Q3
$238M Buy
814,388
+96,843
+13% +$30.2M 0.8% 38
2023
Q2
$245M Sell
717,545
-11,311
-2% -$3.42M 0.86% 35
2023
Q1
$186M Sell
728,856
-8,122
-1% -$2M 0.65% 45
2022
Q4
$196M Sell
736,978
-31,167
-4% -$7.6M 0.72% 42
2022
Q3
$144M Sell
768,145
-45,855
-6% -$9.85M 0.57% 45
2022
Q2
$163M Sell
814,000
-32,202
-4% -$7.55M 0.6% 44
2022
Q1
$255M Sell
846,202
-54,820
-6% -$16M 0.81% 39
2021
Q4
$324M Sell
901,022
-21,421
-2% -$7.37M 0.97% 34
2021
Q3
$306M Buy
922,443
+42,726
+5% +$14.3M 1.01% 33
2021
Q2
$270M Buy
879,717
+7,587
+0.9% +$2.13M 0.9% 37
2021
Q1
$215M Buy
872,130
+2,199
+0.3% +$553K 0.79% 40
2020
Q4
$237M Sell
869,931
-2,256
-0.3% -$560K 0.91% 39
2020
Q3
$206M Sell
872,187
-4,467
-0.5% -$1M 0.88% 38
2020
Q2
$167M Buy
876,654
+172,317
+24% +$30.9M 0.77% 41
2020
Q1
$116M Sell
704,337
-46,101
-6% -$8.44M 0.71% 42
2019
Q4
$148M Buy
750,438
+17,862
+2% +$3.34M 0.71% 43
2019
Q3
$132M Buy
732,576
+111,234
+18% +$19.2M 0.68% 43
2019
Q2
$109M Buy
621,342
+230,475
+59% +$39.5M 0.56% 43
2019
Q1
$74.3M Buy
390,867
+24,708
+7% +$4.39M 0.39% 56
2018
Q4
$58.5M Buy
366,159
+1,017
+0.3% +$172K 0.35% 60
2018
Q3
$69.9M Sell
365,142
-21,900
-6% -$3.89M 0.36% 61
2018
Q2
$61.7M Buy
387,042
+12,762
+3% +$1.95M 0.33% 63
2018
Q1
$51.5M Sell
374,280
-10,695
-3% -$1.49M 0.28% 62
2017
Q4
$46.8M Sell
384,975
-75,510
-16% -$9.45M 0.24% 64
2017
Q3
$53.5M Buy
460,485
+4,032
+0.9% +$439K 0.28% 63
2017
Q2
$47.4M Sell
456,453
-6,876
-1% -$661K 0.25% 66
2017
Q1
$39.5M Buy
463,329
+51,741
+13% +$4.09M 0.21% 71
2016
Q4
$29M Buy
411,588
+179,820
+78% +$13.2M 0.16% 72
2016
Q3
$18.7M Sell
231,768
-8,640
-4% -$662K 0.1% 80
2016
Q2
$17.7M Sell
240,408
-23,580
-9% -$1.66M 0.1% 80
2016
Q1
$17.6M Buy
+263,988
New +$16.4M 0.1% 81
2014
Q3
Sell
-7,965
Closed -$362K 272
2014
Q2
$362K Sell
7,965
-6,453
-45% -$285K ﹤0.01% 209
2014
Q1
$726K Sell
14,418
-1,179,072
-99% -$55.5M ﹤0.01% 160
2013
Q4
$50.9M Buy
+1,193,490
New +$50.2M 0.24% 64
2013
Q2
$67.5M Buy
+1,199,556
New +$66.1M 0.34% 58

Other funds holding ISRG

Fayez Sarofim & Co's ISRG Position: Q1 2026 in Review

Fayez Sarofim & Co increased its Intuitive Surgical (ISRG) stake by 3.4% in Q1 2026, buying an estimated $20.2M and bringing the position to 1,212,411 shares worth $559M. The position accounts for 1.43% of the portfolio, ranked #22.

Fayez Sarofim & Co first reported a position in ISRG in Q2 2013 and has held it in 45 quarters since. The position peaked at $664M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Fayez Sarofim & Co held 1,212,411 shares of Intuitive Surgical worth $559M as of Q1 2026.
  • Fayez Sarofim & Co bought 39,885 Intuitive Surgical shares in Q1 2026, an estimated $20.2M.
  • Intuitive Surgical made up 1.43% of Fayez Sarofim & Co's portfolio in Q1 2026, its #22 holding.
  • Fayez Sarofim & Co first reported a position in Intuitive Surgical in Q2 2013 and has held it in 45 quarters since.
  • Fayez Sarofim & Co's Intuitive Surgical position peaked at $664M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Fayez Sarofim & Co's 13F filing for Q1 2026, filed 15 May 2026.